ORIGINAL RESEARCH
Accepted on 10 Sep 2025
Multi-omics Analysis Reveals Ultraviolet Response Insights for Immunotherapy and Prognosis
doi 10.3389/fimmu.2025.1598070
- 235 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
14k
Total downloads
52k
Total views and downloads
Articles
REVIEW
Published on 31 Jul 2025
The impact of immune checkpoint inhibition on atherosclerosis in cancer patients
doi 10.3389/fimmu.2025.1604989
- 1,398 views
CASE REPORT
Published on 05 Jun 2025
Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
doi 10.3389/fimmu.2025.1557565
- 1,925 views
- 1 citation
CASE REPORT
Published on 30 May 2025
Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient
doi 10.3389/fimmu.2025.1565065
- 1,430 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 May 2025
Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2/HO-1/GPX4 axis
doi 10.3389/fimmu.2025.1558814
- 2,150 views
CORRECTION
Published on 16 May 2025
Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1611591
- 856 views
- 1 citation
REVIEW
Published on 28 Apr 2025
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families
doi 10.3389/fimmu.2025.1499663
- 1,814 views
REVIEW
Published on 28 Apr 2025
ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies
doi 10.3389/fimmu.2025.1550400
- 2,709 views
SYSTEMATIC REVIEW
Published on 26 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1563300
- 4,116 views
CASE REPORT
Published on 24 Mar 2025
Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings
doi 10.3389/fimmu.2025.1543114
- 1,678 views
SYSTEMATIC REVIEW
Published on 11 Mar 2025
Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1542850
- 2,053 views
ORIGINAL RESEARCH
Published on 07 Feb 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity
doi 10.3389/fimmu.2025.1534936
- 2,932 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore